

<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>

</head>

<body>

    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141628065131250%26DBCODE%3dCJFD%26TABLEName%3dCJFDTEMP%26FileName%3dFBYF201906010%26RESULT%3d1%26SIGN%3d9MOsMwRH%252f42zMwWiFaziURWxs4c%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=FBYF201906010&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=FBYF201906010&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>


    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=FBYF201906010&amp;v=MjkzNThRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlublViektJeS9TYUxHNEg5ak1xWTlFWkk=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#41" data-title="1 &lt;b&gt;对象与方法&lt;/b&gt; ">1 <b>对象与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#42" data-title="&lt;b&gt;1.1&lt;/b&gt; 监测对象"><b>1.1</b> 监测对象</a></li>
                                                <li><a href="#45" data-title="&lt;b&gt;1.2&lt;/b&gt; 检测方法"><b>1.2</b> 检测方法</a></li>
                                                <li><a href="#50" data-title="&lt;b&gt;1.3&lt;/b&gt; 统计分析"><b>1.3</b> 统计分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#52" data-title="2 &lt;b&gt;结 果&lt;/b&gt; ">2 <b>结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#53" data-title="&lt;b&gt;2.1&lt;/b&gt; 百白破疫苗免疫成功率监测结果分析"><b>2.1</b> 百白破疫苗免疫成功率监测结果分析</a></li>
                                                <li><a href="#55" data-title="&lt;b&gt;2.2&lt;/b&gt; 麻腮风疫苗免疫成功率监测结果分析"><b>2.2</b> 麻腮风疫苗免疫成功率监测结果分析</a></li>
                                                <li><a href="#59" data-title="&lt;b&gt;2.3&lt;/b&gt; 麻风疫苗免疫成功率监测结果分析"><b>2.3</b> 麻风疫苗免疫成功率监测结果分析</a></li>
                                                <li><a href="#62" data-title="&lt;b&gt;2.4&lt;/b&gt; 乙脑疫苗免疫成功率监测结果分析"><b>2.4</b> 乙脑疫苗免疫成功率监测结果分析</a></li>
                                                <li><a href="#65" data-title="&lt;b&gt;2.5&lt;/b&gt; 脊灰疫苗免疫成功率监测结果分析"><b>2.5</b> 脊灰疫苗免疫成功率监测结果分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#69" data-title="3 &lt;b&gt;讨 论&lt;/b&gt; ">3 <b>讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#68" data-title="&lt;b&gt;表1&lt;/b&gt; 百白破疫苗、麻腮风疫苗、麻风疫苗、乙脑疫苗免疫成功率监测结果"><b>表1</b> 百白破疫苗、麻腮风疫苗、麻风疫苗、乙脑疫苗免疫成功率监测结果</a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="103">


                                    <a id="bibliography_1" >
                                        <b>[1]</b>
                                     张国民,谭楚生,李迪,等.中国5个县(区) 首剂麻疹减毒活疫苗免疫成功率监测分析[J].中国疫苗和免疫,2014,20(2):122-126.</a>
                                </li>
                                <li id="105">


                                    <a id="bibliography_2" >
                                        <b>[2]</b>
                                     王凤双,彭枭然,肖雷,等.2015年北京市顺义区麻风腮疫苗的流腮基础免疫成功率和麻疹、风疹复种效果监测分析[J].中国生物制品学杂志,2016,9(8):844-846.</a>
                                </li>
                                <li id="107">


                                    <a id="bibliography_3" >
                                        <b>[3]</b>
                                     杨德明,张海艳,鞠登会.重庆市涪陵区麻疹风疹及流行性腮腺炎免疫水平分析[J].公共卫生与预防医学,2014,25(3):93-95.</a>
                                </li>
                                <li id="109">


                                    <a id="bibliography_4" >
                                        <b>[4]</b>
                                     李珍.十堰市城区托幼机构健康儿童麻疹、乙脑、甲型肝炎抗体水平分析[J].中国社区医师,2017,33(2):166-167.</a>
                                </li>
                                <li id="111">


                                    <a id="bibliography_5" >
                                        <b>[5]</b>
                                     冯元贵,梁奕卫,阮发妹,等.儋州市适龄儿童白喉、麻疹和乙脑抗体水平监测分析[J].中国热带医学,2015,15(9):1089-1091.</a>
                                </li>
                                <li id="113">


                                    <a id="bibliography_6" title=" BIANCHI F P,STEFANIZZI P,DE NITTO S,et al.Long-term immunogenicity of Measles vaccine:an Italian retrospective cohort study[J].J Infect Dis,2019:508-522." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Long-term immunogenicity of Measles vaccine:an Italian retrospective cohort study">
                                        <b>[6]</b>
                                         BIANCHI F P,STEFANIZZI P,DE NITTO S,et al.Long-term immunogenicity of Measles vaccine:an Italian retrospective cohort study[J].J Infect Dis,2019:508-522.
                                    </a>
                                </li>
                                <li id="115">


                                    <a id="bibliography_7" title=" VOS R A,MOLLEMA L,VAN BINNENDIJK R,et al.Seroepidemiology of Measles,Mumps and Rubella on Bonaire,St.Eustatius and Saba:The First Population-Based Serosurveillance Study in Caribbean Netherlands[J].Vaccines (Basel),2019,7(4):37-60." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Seroepidemiology of Measles,Mumps and Rubella on Bonaire,St.Eustatius and Saba:The First Population-Based Serosurveillance Study in Caribbean Netherlands">
                                        <b>[7]</b>
                                         VOS R A,MOLLEMA L,VAN BINNENDIJK R,et al.Seroepidemiology of Measles,Mumps and Rubella on Bonaire,St.Eustatius and Saba:The First Population-Based Serosurveillance Study in Caribbean Netherlands[J].Vaccines (Basel),2019,7(4):37-60.
                                    </a>
                                </li>
                                <li id="117">


                                    <a id="bibliography_8" >
                                        <b>[8]</b>
                                     刘浩,林希建,胡强.长沙市人群脊髓灰质炎免疫水平及免疫成功率分析[J].中国热带医学,2014,14(1):60-61.</a>
                                </li>
                                <li id="119">


                                    <a id="bibliography_9" >
                                        <b>[9]</b>
                                     杨北方,张迟,赵明江,等.湖北省2010年健康人群脊髓灰质炎疫苗免疫效果分析[J].公共卫生与预防医学,2013,24(4):77-78.</a>
                                </li>
                                <li id="121">


                                    <a id="bibliography_10" title=" HOTTA C,OGAWA T,SHIRASAWA H.Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine[J].Hum Vaccin Immunother,2019,15(5):1154-1159." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine">
                                        <b>[10]</b>
                                         HOTTA C,OGAWA T,SHIRASAWA H.Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine[J].Hum Vaccin Immunother,2019,15(5):1154-1159.
                                    </a>
                                </li>
                                <li id="123">


                                    <a id="bibliography_11" title=" FARAG N H,WANNEMUEHLER K,WELDON W,et al.Estimating population immunity to poliovirus in Jordan&#39;s high-risk areas[J].Hum Vaccin Immunother,2019(166):77-104." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Estimating population immunity to poliovirus in Jordan&amp;#39;&amp;#39;s high-risk areas">
                                        <b>[11]</b>
                                         FARAG N H,WANNEMUEHLER K,WELDON W,et al.Estimating population immunity to poliovirus in Jordan&#39;s high-risk areas[J].Hum Vaccin Immunother,2019(166):77-104.
                                    </a>
                                </li>
                                <li id="125">


                                    <a id="bibliography_12" >
                                        <b>[12]</b>
                                     骆淑英,吴非,陶静波,等.2015—2016年浙江省义乌市健康人群乙型脑炎抗体水平调查[J].中国疫苗和免疫,2017,23(6):634-637.</a>
                                </li>
                                <li id="127">


                                    <a id="bibliography_13" >
                                        <b>[13]</b>
                                     蔡军,朱宝,郑珂,等.2014年成都市健康人群乙脑、乙肝抗体水平监测[J].预防医学情报杂志,2016,32(9):898-901.</a>
                                </li>
                                <li id="129">


                                    <a id="bibliography_14" >
                                        <b>[14]</b>
                                     唐莹,王凤双,肖雷,等.2014 年北京市顺义区健康人群乙型脑炎抗体水平监测[J].中国卫生检验杂志,2016,26(13):1922-1924.</a>
                                </li>
                                <li id="131">


                                    <a id="bibliography_15" >
                                        <b>[15]</b>
                                     YUN K W,LEE H J,PARK J Y,et al.Long-term immunogenicity of an initial booster dose of an inactivated,Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with aninactivated,mouse brain-derived Japanese encephalitis vaccine[J].Vaccine,2018,36(11):1398-1404.</a>
                                </li>
                                <li id="133">


                                    <a id="bibliography_16" title=" STAEHELIN C,CHERNET A,SYDOW V,et al.Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland:a cross-sectional study[J].J Travel Med,2019,26(6):1-35." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland:a cross-sectional study">
                                        <b>[16]</b>
                                         STAEHELIN C,CHERNET A,SYDOW V,et al.Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland:a cross-sectional study[J].J Travel Med,2019,26(6):1-35.
                                    </a>
                                </li>
                                <li id="135">


                                    <a id="bibliography_17" title=" WILKINSON K,RIGHOLT,C H,KWONG J C,et al.A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba,Canada,1992-2015:A Canadian Immunization Research Network Study[J].Vaccine,2019:64." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba,Canada,1992-2015:A Canadian Immunization Research Network Study">
                                        <b>[17]</b>
                                         WILKINSON K,RIGHOLT,C H,KWONG J C,et al.A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba,Canada,1992-2015:A Canadian Immunization Research Network Study[J].Vaccine,2019:64.
                                    </a>
                                </li>
                                <li id="137">


                                    <a id="bibliography_18" >
                                        <b>[18]</b>
                                     刘新利,樊永军.2012年陕西省铜川市百白破疫苗免疫成功率监测分析[J].疾病监测,2013,28(2):109-111.</a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=FBYF" target="_blank">公共卫生与预防医学</a>
                2019,30(06),40-43 DOI:10.3969/j.issn.1006-2483.2019.06.010            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm">湖北省部分免疫规划疫苗免疫成功率监测分析</span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%AA%86%E9%87%91%E4%BF%8A&amp;code=38620346&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">骆金俊</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E7%8E%8B%E5%9B%9B%E5%85%A8&amp;code=34181350&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">王四全</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E7%8E%8B%E9%9B%B7&amp;code=26382166&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">王雷</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%BC%A0%E8%BF%9F&amp;code=11307676&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">张迟</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E8%B5%B5%E6%98%8E%E6%B1%9F&amp;code=07388864&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">赵明江</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E6%B9%96%E5%8C%97%E7%9C%81%E7%96%BE%E7%97%85%E9%A2%84%E9%98%B2%E6%8E%A7%E5%88%B6%E4%B8%AD%E5%BF%83&amp;code=0010831&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">湖北省疾病预防控制中心</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b> 了解湖北省免疫规划疫苗接种后免疫效果,为制定湖北省免疫规划策略提供科学依据。<b>方法</b> 选取湖北省3个县(市)开展免疫规划疫苗免疫成功率监测,分别监测目标人群百白破(DTaP)、麻风(MR)、麻腮风(MMR)、乙脑(JEV-L)、脊灰(OPV)5种疫苗针对疾病的疫苗免疫效果。<b>结果</b> DTaP中百日咳、白喉、破伤风免疫成功率为38.00%、100%、100%,免疫前后,百日咳抗体阳性率差异无统计学意义(<i>χ</i><sup>2</sup>=3.048,<i>P</i>&gt;0.05),白喉和破伤风抗体阳性率差异均有统计学意义(白喉:<i>χ</i><sup>2</sup>=100.00,<i>P</i>&lt;0.01;破伤风:<i>χ</i><sup>2</sup>=88.679,<i>P</i>&lt;0.01);MR中麻疹、风疹免疫成功率为100%、98.00%,免疫前后,麻疹和风疹抗体阳性率差异均有统计学意义(麻疹:<i>χ</i><sup>2</sup>=92.308,<i>P</i>&lt;0.01;风疹:<i>χ</i><sup>2</sup>=6.737,<i>P</i>&lt;0.05);MMR中麻疹、流腮、风疹免疫成功率均为100%,免疫前后,麻疹抗体阳性率差异有统计学意义(<i>χ</i><sup>2</sup>=8.701,<i>P</i>&lt;0.05),流腮和风疹抗体阳性率差异均无统计学意义(<i>χ</i><sup>2</sup>=0.000,<i>P</i>&gt;0.05);JEV-L中乙脑免疫成功率为76.00%,免疫前后,乙脑抗体阳性率差异有统计学意义(<i>χ</i><sup>2</sup>=57.545,<i>P</i>&lt;0.01);OPV中脊灰免疫成功率为96.00%,免疫后,脊灰Ⅰ型中和抗体阳性率和Ⅲ型中和抗体阳性率均无统计学意义(<i>χ</i><sup>2</sup>=0.000,<i>P</i>&gt;0.05)。<b>结论</b> 5种疫苗免疫成功率总体良好,但有必要优化百日咳菌苗和乙脑疫苗免疫程序,提升疫苗抗体免疫成功率,才能降低相关疾病的发病风险。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%85%8D%E7%96%AB%E8%A7%84%E5%88%92&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">免疫规划;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%96%AB%E8%8B%97&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">疫苗;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%85%8D%E7%96%AB%E6%88%90%E5%8A%9F%E7%8E%87&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">免疫成功率;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                            <b>作者简介：</b>
                                                        <span>
                                    骆金俊,主管医师,硕士研究生,主要研究方向:免疫规划;
                                </span>
                                <span>
                                    *赵明江,副主任技师,Email:13295949@qq.com;
                                </span>
                    </p>
                                    <p><b>收稿日期：</b>2019-10-08</p>

            </div>
                    <h1><b>Monitoring and analysis of vaccine immunization success rate of some immunization programs in Hubei Province</b></h1>
                    <h2>
                    <span>LUO Jinjun</span>
                    <span>WANG Siquan</span>
                    <span>WANG Lei</span>
                    <span>ZHANG Chi</span>
                    <span>ZHAO Mingjiang</span>
            </h2>
                    <h2>
                    <span>Hubei Provincial Center for Disease Control and Prevention</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b> To understand the immunization effect after vaccination in Hubei Province, and to provide a scientific basis for the development of immunization programs strategy. <b>Methods</b> Three counties(cities) in Hubei Province were selected to carry out the surveillance of the success rate of immunization with the vaccine. The immunization effects of 5 vaccines was monitored, including diphtheria, tetanus and acellular pertussis combined vaccine(DTaP),measles and rubella combined attenuated live vaccine( MR),measles,mumps and rubella combined attenuated live vaccine(MMR), Japanese encephalitis attenuated live vaccine(JEV-L), and oral poliomyelitis attenuated live vaccine(OPV) in the target population. <b>Results</b> Immunization success rates of pertussis, diphtheria and tetanus were 38.00%, 100% and 100% in DTaP. There was no significant difference in the positive rate of pertussis antibody before and after immunization(<i>χ</i><sup>2</sup>=3.048, <i>P</i>&gt;0.05).The positive rates of the antibody of diphtheria and tetanus were all statistically significant(diphtheria:<i>χ</i><sup>2</sup>=100.000, <i>P</i>&lt;0.01; tetanus:<i>χ</i><sup>2</sup>=88.679,<i>P</i>&lt;0.01). The immunization success rates of measles and rubella were 100% and 98.00% in MR, and the positive rates of measles and rubella antibody were all statistically significant before and after immunization(measles:<i>χ</i><sup>2</sup>=92.308, <i>P</i>&lt;0.01; rubella: <i>χ</i><sup>2</sup>=6.737, <i>P</i>&lt;0.05). The immunization success rate of measles, mumps and rubella were all 100% in MMR. The positive rate of measles antibody was statistically significant before and after immunization(<i>χ</i><sup>2</sup>=8.701, <i>P</i>&lt;0.05), while there was no significant difference in the positive rate of mumps and rubella antibody(<i>χ</i><sup>2</sup>=0.000, <i>P</i>&gt;0.05). The immunization success rate of Japanese encephalitis was 76.00% in JEV-L, and the positive rate of Japanese encephalitis antibody was statistically significant(<i>χ</i><sup>2</sup>=57.545, <i>P</i>&lt;0.05) before and after immunization. The immunization success rate of oral poliomyelitis was 96.00% in OPV. There was no significant difference for the positive rate of both type I and type III neutralizing antibodies in polio after immunization(<i>χ</i><sup>2</sup>=0.000,<i>P</i>&gt;0.05). <b>Conclusion</b> The immunization success rate of the five immunization programming vaccines was generally good, but it is necessary to optimize the immunization programs including pertussis vaccine and JEV-L vaccine, and to enhance the immunization success rate of vaccine antibody, in order to reduce the risk of related diseases.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Immunization%20programs&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Immunization programs;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Vaccine&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Vaccine;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Immunization%20success%20rate&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Immunization success rate;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                            <b>Author：</b>
                                                        <span>
                                    ZHAO Mingjiang, Email:13295949@qq.com;
                                </span>
                    </p>
                                    <p><b>Received：</b> 2019-10-08</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="40">自扩大国家免疫规划政策实施以来,免疫规划疫苗种类已增至11种,免疫规划工作虽然取得巨大成效,但是近年来我省麻疹、风疹、流腮、百日咳等疫苗针对传染病疫情持续走高,部分地区暴发疫情时有发生,免疫规划疫苗实施效果如何,有待探讨。研究通过对湖北省部分免疫规划疫苗免疫成功率监测情况进行分析,初步探讨全省免疫规划疫苗实施效果,为制定全省免疫规划策略提供科学依据。湖北省疾控中心组织专家制定了《湖北省免疫规划疫苗免疫成功率监测方案》,监测工作每4年开展一次,每次选取部分县(市)开展部分免疫规划疫苗成功率监测,首次监测工作从2015年开始,现针对第一阶段监测结果(主要是DTaP、MR、MMR、JEV-L、OPV)开展了研究。</p>
                </div>
                <h3 id="41" name="41" class="anchor-tag">1 <b>对象与方法</b></h3>
                <h4 class="anchor-tag" id="42" name="42"><b>1.1</b> 监测对象</h4>
                <div class="p1">
                    <p id="43">监测目标人群无细胞百白破联合疫苗(简称百白破,DTaP)、麻疹风疹联合减毒活疫苗(简称麻风,MR)、麻疹流腮风疹联合减毒活疫苗 (简称麻腮风,MMR)、流行性乙型脑炎减毒活疫苗(简称乙脑,JEV-L)、脊灰减毒活疫苗(简称脊灰,OPV)5 种疫苗针对疾病的疫苗免疫成功率,其中目标人群依次为:百白破免疫前3月龄、免疫后6月龄;麻腮风免疫前18月龄、免疫后19月龄;麻风免疫前8月龄、免疫后9月龄;乙脑免疫前8月龄、免疫后9月龄;脊灰免疫后5月龄。</p>
                </div>
                <h4 class="anchor-tag" id="102" name="102">1.1.1样本量及抽样</h4>
                <div class="p1">
                    <p id="44">根据样本量计算公式<citation id="139" type="reference"><link href="103" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation> n=U<mathml id="76"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msubsup><mrow></mrow><mtext>α</mtext><mn>2</mn></msubsup></mrow></math></mathml>π(1-π)/δ2,取π=80%,δ=12%,U =0.05,双侧概率计算得到样本量最低为43。选取湖北省3个县(市)作为研究现场,考虑失访等因素,分别抽取至少50名观察对象。每个县(市)选择 1 个城区和 1 个乡镇;在城区(乡镇)随机抽取1 个社区(村),在该社区(村)抽取25名目标人群,每县(市)共计50 人;若在 1 个社区(村)内目标儿童数达不到规定样本量,则在临近的社区(村)抽取。</p>
                </div>
                <h4 class="anchor-tag" id="45" name="45"><b>1.2</b> 检测方法</h4>
                <h4 class="anchor-tag" id="46" name="46"><b>1.2.1</b> 标本采集、运送和保存</h4>
                <div class="p1">
                    <p id="47">每人采集静脉血2～5mL,现场贴上标签,分离血清,放置-20℃冰箱保存,带冰运送,避免反复冻融。 除脊灰疫苗监测仅需采集免后血样(50份)外,其他4种疫苗均需免前免后各采集一次血样(各50份,共100份)。</p>
                </div>
                <h4 class="anchor-tag" id="48" name="48"><b>1.2.2</b> 标本检测</h4>
                <div class="p1">
                    <p id="49">所有血样均由省疾控中心实验室开展检测,按照免疫针对疾病的实验室监测方法和判断标准,测定相关抗体滴度,免疫后抗体滴度是免疫前的4倍增长、免疫前阴性免疫后阳性、或者免疫前和免疫后都是阳性算免疫成功。其中脊灰中和抗体滴度&gt;4为阳性,Ⅰ型中和抗体和Ⅲ型中和抗体都是阳性算免疫成功。</p>
                </div>
                <h4 class="anchor-tag" id="50" name="50"><b>1.3</b> 统计分析</h4>
                <div class="p1">
                    <p id="51">用Epidata 3.0建立数据库,运用SPSS 20.0进行数据统计分析,以<i>P</i>&lt;0.05有统计学意义。</p>
                </div>
                <h3 id="52" name="52" class="anchor-tag">2 <b>结 果</b></h3>
                <h4 class="anchor-tag" id="53" name="53"><b>2.1</b> 百白破疫苗免疫成功率监测结果分析</h4>
                <div class="p1">
                    <p id="54">监测数据显示百日咳、白喉、破伤风的免疫成功率分别为38.00%、100.00%和100.00%。免疫前百日咳、白喉、破伤风抗体阳性率分别为22.00%、0.00%和6.00%;免疫后百日咳、白喉、破伤风抗体阳性率分别为38.00%、100.00%和100.00%。免疫前后,百日咳抗体阳性率差异无统计学意义(<i>χ</i><sup>2</sup>=3.048,<i>P</i>=0.126),白喉和破伤风抗体阳性率差异有统计学意义(白喉:<i>χ</i><sup>2</sup>=100.00,<i>P</i>=0.000;破伤风:<i>χ</i><sup>2</sup>=88.679,<i>P</i>=0.000)(表1)。监测结果显示,无细胞百白破疫苗中,白喉和破伤风类毒素免疫效果良好,而百日咳菌苗免疫效果欠佳。</p>
                </div>
                <h4 class="anchor-tag" id="55" name="55"><b>2.2</b> 麻腮风疫苗免疫成功率监测结果分析</h4>
                <div class="p1">
                    <p id="56">监测数据显示麻疹、流腮、风疹的免疫成功率分别为100%、100%和100%。配对血样免疫前麻疹、流腮、风疹抗体阳性率分别为88.00%、100和100%;免疫后麻疹、流腮、风疹抗体抗体阳性率分别为100%、100%和100%。免疫前后,麻疹抗体阳性率差异有统计学意义(<i>χ</i><sup>2</sup>=8.701,<i>P</i>=0.027),流腮和风疹抗体阳性率差异均无统计学意义(<i>χ</i><sup>2</sup>=0.000,<i>P</i>=1)(表1)。</p>
                </div>
                <div class="p1">
                    <p id="57">监测结果显示,麻腮风疫苗中,麻疹、流腮、风疹免疫效果良好。</p>
                </div>
                <div class="p1">
                    <p id="58">麻腮风疫苗接种后,麻疹、流腮、风疹抗体水平均达到100.00%,对目标人群起到了很好的保护作用,疫苗效果良好。</p>
                </div>
                <h4 class="anchor-tag" id="59" name="59"><b>2.3</b> 麻风疫苗免疫成功率监测结果分析</h4>
                <div class="p1">
                    <p id="60">监测数据显示麻疹、风疹的免疫成功率分别为100.00%和98.00%。配对血样免疫前麻疹、风疹抗体阳性率分别为4.00%和84.00%;免疫后麻疹、风疹抗体阳性率分别为100.00%和98.00%。免疫前后,麻疹和风疹抗体阳性率差异有统计学意义(麻疹:<i>χ</i><sup>2</sup>=92.308,<i>P</i>=0.000;风疹:<i>χ</i><sup>2</sup>=6.737,<i>P</i>=0.031)(表1)。</p>
                </div>
                <div class="p1">
                    <p id="61">监测结果显示,麻风疫苗中,麻疹和风疹免疫效果良好。麻风疫苗接种后,麻疹和风疹抗体水平分别达到100%和98.00%,对目标人群起到了很好的保护作用,疫苗效果良好。</p>
                </div>
                <h4 class="anchor-tag" id="62" name="62"><b>2.4</b> 乙脑疫苗免疫成功率监测结果分析</h4>
                <div class="p1">
                    <p id="63">监测数据显示乙脑的免疫成功率为76.00%。配对血样免疫前乙脑抗体阳性率为2.00%;免疫后乙脑抗体阳性率为76.00%。免疫前后,乙脑抗体阳性率差异有统计学意义(<i>χ</i><sup>2</sup>=57.545,<i>P</i>=0.000)(表1)。</p>
                </div>
                <div class="p1">
                    <p id="64">监测结果显示,乙脑疫苗接种后,乙脑抗体水平达到76.00%,对目标人群起到了一定的保护作用,但不足以在人群中建立范围更广的免疫屏障。因此,要进一步加强疫苗研发,以提升疫苗更高的保护力。</p>
                </div>
                <h4 class="anchor-tag" id="65" name="65"><b>2.5</b> 脊灰疫苗免疫成功率监测结果分析</h4>
                <div class="p1">
                    <p id="66">50份脊灰疫苗的免疫成功率为96.00%(48/50)。Ⅰ型中和抗体阳性率为98.00%(49/50);Ⅲ型中和抗体体阳性率为98.00%(49/50)。免疫后,脊灰Ⅰ型中和抗体阳性率和Ⅲ型中和抗体阳性率差异无统计学意义(<i>χ</i><sup>2</sup>=0.000,<i>P</i>=1)。</p>
                </div>
                <div class="p1">
                    <p id="67">监测结果显示,脊灰免疫效果良好。脊灰疫苗接种后,Ⅰ型中和抗体和Ⅲ型中和抗体水平均达到98.00%,对目标人群起到了很好的保护作用,疫苗效果良好。</p>
                </div>
                <div class="area_img" id="68">
                                            <p class="img_tit">
                                                <b>表1</b> 百白破疫苗、麻腮风疫苗、麻风疫苗、乙脑疫苗免疫成功率监测结果
                                                    <br />
                                                <b>Table 1</b> Monitoring results of immunization success rate of DTaP, MMR, MR, JEV-L
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/FBYF201906010_06800.jpg&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/FBYF201906010_06800.jpg&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/FBYF201906010_06800.jpg&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表1 百白破疫苗、麻腮风疫苗、麻风疫苗、乙脑疫苗免疫成功率监测结果" src="Detail/GetImg?filename=images/FBYF201906010_06800.jpg&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>

                </div>
                <h3 id="69" name="69" class="anchor-tag">3 <b>讨 论</b></h3>
                <div class="p1">
                    <p id="70">疫苗免疫成功率监测主要用于考核和评价疫苗的接种质量和效果,通过免疫成功率监测,可以分析影响免疫成功率的各种因素,有助于查找可能存在的疫苗质量、疫苗储存运输及免疫服务管理方面存在的问题,促进免疫规划整体工作开展<citation id="140" type="reference"><link href="103" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="71">湖北省麻腮风疫苗和麻风疫苗免疫效果良好(≥98%),对目标人群具有很好的保护作用,这与一些国内外研究报道基本相符,其中北京市顺义区麻腮风疫苗中麻疹、流腮、风疹免疫后抗体阳转率为分别为100.00%、97.22%和100.00%<citation id="141" type="reference"><link href="105" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>,江苏省麻腮风联合疫苗麻疹、风疹和流腮抗体阳性率分别为100.00%、 93.91%和 96.46%,重庆市涪陵区麻疹、风疹和流腮抗体阳性率分别为93.52%、 89.79%和90.70%<citation id="142" type="reference"><link href="107" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>,十堰市城区托幼机构健康儿童麻疹抗体保护率达到99.60%<citation id="143" type="reference"><link href="109" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>,海南省儋州市适龄儿童麻疹抗体阳性率为95.35%<sup>[5</sup>,意大利一项研究<citation id="144" type="reference"><link href="113" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>表明人群麻疹的免疫原性达到93.00%,一项关于加勒比海地区人群血清学研究表明<citation id="145" type="reference"><link href="115" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>麻疹的总体血清阳性率为94%且腮腺炎和风疹的总体血清阳性率相对较低(均为85%)。各地麻类免疫成功率水平不一致,可能受疫苗免疫原性、抗原剂量、疫苗质量、儿童个体的遗传背景等很多因素的影响,也可能与免疫前的抗体水平有直接关系<citation id="146" type="reference"><link href="103" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="72">湖北省脊灰疫苗中脊灰的免疫成功率为96.00%,其中Ⅰ型中和抗体和Ⅲ型中和抗体水平均达到98%,这与长沙市人群脊灰免疫水平Ⅰ型、Ⅲ型脊灰抗体阳性分别为94.0%和91.1% <citation id="147" type="reference"><link href="117" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>及湖北省2010年监测Ⅰ型、Ⅲ型脊灰抗体阳性96.26%和86.49%<citation id="148" type="reference"><link href="119" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>的研究结果基本相符,也与日本接种脊灰疫苗后血清阳性率超过90%<citation id="149" type="reference"><link href="121" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>和约旦社区调查人群脊灰抗体阳性Ⅰ型(≥98%)、Ⅲ型(≥96%)<citation id="150" type="reference"><link href="123" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>的结果相符,说明脊灰疫苗效果良好,对目标人群起到了很好的保护作用。</p>
                </div>
                <div class="p1">
                    <p id="73">湖北省乙脑疫苗中乙脑的免疫成功率为76.00%,对目标人群起到了一定的保护作用,与一些研究报道基本相符,其中义乌市乙脑阳性率为37.88%<citation id="151" type="reference"><link href="125" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>,成都市健康人群中乙脑抗体阳性率为41.89%<citation id="152" type="reference"><link href="127" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>,扬州市健康人群中乙脑抗体阳性率为60.11%,十堰市城区托幼机构健康儿童乙脑抗体保护率74.6%<citation id="153" type="reference"><link href="109" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>,北京顺义区健康人群乙脑抗体阳性率为83.95%<citation id="154" type="reference"><link href="129" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>,儋州市适龄儿童乙脑抗体阳性率为84.43%<citation id="155" type="reference"><link href="111" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>,荷兰一项研究<citation id="156" type="reference"><link href="131" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>表明儿童中乙脑疫苗儿童中和抗体的血清保护率为88.5%。各地乙脑免疫成功率水平不一致,可能是传统的乙脑减毒疫苗抗体产生概率高,但持久性不强<citation id="157" type="reference"><link href="109" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>,同时城市化建设的推进,媒介蚊虫的活动范围发生了改变,人群自然感染机会下降,机体不能产生高水平抗体<citation id="158" type="reference"><link href="129" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>。有研究<citation id="159" type="reference"><link href="129" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>报道人群乙脑抗体水平在70%以上就不易发生乙型脑炎流行,故湖北地区已形成一定的免疫屏障,不易发生乙脑流行,但不足以在人群中建立范围更广的免疫屏障。因此要进一步加强疫苗研发,以提升疫苗更高的保护力,同时建议调整乙脑疫苗的免疫程序,恢复6周岁复种1剂次乙脑疫苗的免疫程序<citation id="160" type="reference"><link href="109" rel="bibliography" /><link href="131" rel="bibliography" /><sup>[<a class="sup">4</a>,<a class="sup">15</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="74">湖北省无细胞百白破疫苗接种后,白喉和破伤风抗体免疫成功率均达到100%,与瑞士白喉血清阳性率74.8%和破伤风血清阳性率94.8%的研究<citation id="161" type="reference"><link href="133" rel="bibliography" /><sup>[<a class="sup">16</a>]</sup></citation>基本相符,说明白喉和破伤风的免疫效果较好,而百日咳免疫成功率依然较低(38.00%),与突尼斯儿童百日咳血清阳性仅为12.8%和加拿大曼尼托巴省百日咳非暴发年份为35%<citation id="162" type="reference"><link href="135" rel="bibliography" /><sup>[<a class="sup">17</a>]</sup></citation>的阳性率基本相符,分析原因百日咳抗体几何平均浓度衰减极快,半衰期仅3～4个月<citation id="163" type="reference"><link href="137" rel="bibliography" /><sup>[<a class="sup">18</a>]</sup></citation>,不足以在人群中建立有效的免疫屏障,此外,免疫前人群中百日咳抗体阳性率也达到一定水平(22.00%),说明部分婴幼儿在接种百白破疫苗前已感染了百日咳杆菌,若不能建立有效的百日咳免疫屏障,百日咳疫情将有扩散趋势。因此,国家层面应抓紧对免疫效果更好的百日咳疫苗的研发,以有效防控百日咳疫情,除了疫苗研发外,还需对现行的百日咳免疫程序进行研讨,以探寻最优的百日咳免疫策略,必要时进行加强免疫。</p>
                </div>
                <div class="p1">
                    <p id="75">综上,5种免疫规划疫苗免疫成功率总体良好,但有必要优化百日咳菌苗和乙脑疫苗免疫程序,提升疫苗抗体免疫成功率,才能降低相关疾病的发病风险。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="103">
                            <a id="bibliography_1" >
                                    <b>[1]</b>
                                 张国民,谭楚生,李迪,等.中国5个县(区) 首剂麻疹减毒活疫苗免疫成功率监测分析[J].中国疫苗和免疫,2014,20(2):122-126.
                            </a>
                        </p>
                        <p id="105">
                            <a id="bibliography_2" >
                                    <b>[2]</b>
                                 王凤双,彭枭然,肖雷,等.2015年北京市顺义区麻风腮疫苗的流腮基础免疫成功率和麻疹、风疹复种效果监测分析[J].中国生物制品学杂志,2016,9(8):844-846.
                            </a>
                        </p>
                        <p id="107">
                            <a id="bibliography_3" >
                                    <b>[3]</b>
                                 杨德明,张海艳,鞠登会.重庆市涪陵区麻疹风疹及流行性腮腺炎免疫水平分析[J].公共卫生与预防医学,2014,25(3):93-95.
                            </a>
                        </p>
                        <p id="109">
                            <a id="bibliography_4" >
                                    <b>[4]</b>
                                 李珍.十堰市城区托幼机构健康儿童麻疹、乙脑、甲型肝炎抗体水平分析[J].中国社区医师,2017,33(2):166-167.
                            </a>
                        </p>
                        <p id="111">
                            <a id="bibliography_5" >
                                    <b>[5]</b>
                                 冯元贵,梁奕卫,阮发妹,等.儋州市适龄儿童白喉、麻疹和乙脑抗体水平监测分析[J].中国热带医学,2015,15(9):1089-1091.
                            </a>
                        </p>
                        <p id="113">
                            <a id="bibliography_6" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Long-term immunogenicity of Measles vaccine:an Italian retrospective cohort study">

                                <b>[6]</b> BIANCHI F P,STEFANIZZI P,DE NITTO S,et al.Long-term immunogenicity of Measles vaccine:an Italian retrospective cohort study[J].J Infect Dis,2019:508-522.
                            </a>
                        </p>
                        <p id="115">
                            <a id="bibliography_7" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Seroepidemiology of Measles,Mumps and Rubella on Bonaire,St.Eustatius and Saba:The First Population-Based Serosurveillance Study in Caribbean Netherlands">

                                <b>[7]</b> VOS R A,MOLLEMA L,VAN BINNENDIJK R,et al.Seroepidemiology of Measles,Mumps and Rubella on Bonaire,St.Eustatius and Saba:The First Population-Based Serosurveillance Study in Caribbean Netherlands[J].Vaccines (Basel),2019,7(4):37-60.
                            </a>
                        </p>
                        <p id="117">
                            <a id="bibliography_8" >
                                    <b>[8]</b>
                                 刘浩,林希建,胡强.长沙市人群脊髓灰质炎免疫水平及免疫成功率分析[J].中国热带医学,2014,14(1):60-61.
                            </a>
                        </p>
                        <p id="119">
                            <a id="bibliography_9" >
                                    <b>[9]</b>
                                 杨北方,张迟,赵明江,等.湖北省2010年健康人群脊髓灰质炎疫苗免疫效果分析[J].公共卫生与预防医学,2013,24(4):77-78.
                            </a>
                        </p>
                        <p id="121">
                            <a id="bibliography_10" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine">

                                <b>[10]</b> HOTTA C,OGAWA T,SHIRASAWA H.Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine[J].Hum Vaccin Immunother,2019,15(5):1154-1159.
                            </a>
                        </p>
                        <p id="123">
                            <a id="bibliography_11" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Estimating population immunity to poliovirus in Jordan&amp;#39;&amp;#39;s high-risk areas">

                                <b>[11]</b> FARAG N H,WANNEMUEHLER K,WELDON W,et al.Estimating population immunity to poliovirus in Jordan's high-risk areas[J].Hum Vaccin Immunother,2019(166):77-104.
                            </a>
                        </p>
                        <p id="125">
                            <a id="bibliography_12" >
                                    <b>[12]</b>
                                 骆淑英,吴非,陶静波,等.2015—2016年浙江省义乌市健康人群乙型脑炎抗体水平调查[J].中国疫苗和免疫,2017,23(6):634-637.
                            </a>
                        </p>
                        <p id="127">
                            <a id="bibliography_13" >
                                    <b>[13]</b>
                                 蔡军,朱宝,郑珂,等.2014年成都市健康人群乙脑、乙肝抗体水平监测[J].预防医学情报杂志,2016,32(9):898-901.
                            </a>
                        </p>
                        <p id="129">
                            <a id="bibliography_14" >
                                    <b>[14]</b>
                                 唐莹,王凤双,肖雷,等.2014 年北京市顺义区健康人群乙型脑炎抗体水平监测[J].中国卫生检验杂志,2016,26(13):1922-1924.
                            </a>
                        </p>
                        <p id="131">
                            <a id="bibliography_15" >
                                    <b>[15]</b>
                                 YUN K W,LEE H J,PARK J Y,et al.Long-term immunogenicity of an initial booster dose of an inactivated,Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with aninactivated,mouse brain-derived Japanese encephalitis vaccine[J].Vaccine,2018,36(11):1398-1404.
                            </a>
                        </p>
                        <p id="133">
                            <a id="bibliography_16" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland:a cross-sectional study">

                                <b>[16]</b> STAEHELIN C,CHERNET A,SYDOW V,et al.Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland:a cross-sectional study[J].J Travel Med,2019,26(6):1-35.
                            </a>
                        </p>
                        <p id="135">
                            <a id="bibliography_17" target="_blank" href="http://scholar.cnki.net/result.aspx?q=A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba,Canada,1992-2015:A Canadian Immunization Research Network Study">

                                <b>[17]</b> WILKINSON K,RIGHOLT,C H,KWONG J C,et al.A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba,Canada,1992-2015:A Canadian Immunization Research Network Study[J].Vaccine,2019:64.
                            </a>
                        </p>
                        <p id="137">
                            <a id="bibliography_18" >
                                    <b>[18]</b>
                                 刘新利,樊永军.2012年陕西省铜川市百白破疫苗免疫成功率监测分析[J].疾病监测,2013,28(2):109-111.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="FBYF201906010" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>


    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=FBYF201906010&amp;v=MjkzNThRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlublViektJeS9TYUxHNEg5ak1xWTlFWkk=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>


    <link href="/kxreader/Content/css/LeftDetail?v=vAscMyvIPP9NePnbGPkqJ0A5tHOvnzl65tGuRDsf9xg1" rel="stylesheet"/>

</body>
</html>

